🔎 Trials Near Me

Home › Kanser sa Baga › Wisconsin › Madison

Pag-aaral pangklinika para sa Kanser sa Baga sa Madison, WI

Isang pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Madison. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Nagre-recruitPhase 1
  • Wisconsin Institute for Medical Research, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3
  • SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • University of Wisconsin- Madison, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Nagre-recruitPhase 2
  • University of Wisconsin, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 8, 2026 · NCT04919382

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Nagre-recruitPhase 2
  • University of Wisconsin, Madison
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 27, 2025 · NCT03175224

Pag-aaral para sa Kanser sa Baga sa ibang lungsod

Iba pang pag-aaral sa Madison

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.